Gilead Sciences to Present at the Deutsche Bank 36th Annual Health Care Conference on Tuesday, May 3

Webcast Available Through Gilead Corporate Website

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its corporate presentation will be webcast from the Deutsche Bank 36th Annual Health Care Conference in Boston.

John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, will provide an overview of the company on Tuesday, May 3 at 2:50 p.m. Eastern Time.

To access the live webcast or a replay via the internet log on to www.gilead.com. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).



CONTACT:

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor Relations

KEYWORDS:   United States  North America  California  Massachusetts

INDUSTRY KEYWORDS:   Health  Biotechnology  Hospitals  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

Versantis will use the €16 million to trial a drug designed to remove toxic metabolites from liver disease patients.

The Merck-backed round positions Themis to take its chikungunya vaccine through phase 3 and start testing a cancer drug in humans.

No biohazardous substances were in the room where the explosion happened, according to the Russian virology center.